Research libraryMOLEKUL / SOURCE RECORD

Correction of Negative Effect of Antenatal Hypoxia on Liver Tissue Homeostasis in Newborn Albino Rats with Opioid Peptides

Pinaeva OG, Sazonova EN, Lebed'ko OA, Timoshin SS · 2016 · Bulletin of experimental biology and medicine. 2016;162(2):203. PMID 27909965

Animal / experimentalEnglish abstractSource linked

Postnatal offspring treatment · Pregnancy and offspring evidence review ↗

Reported findings and study design

Narrative findings; numerical extraction incomplete

Neonatal Dalargin reportedly normalized liver growth/proliferation and nucleolar measures after prenatal hypoxia. The non-opioid analogue did not normalize all measures. Both reduced oxidative-stress indices; neither was administered to pregnant animals in this study.

Dalargin or a non-opiate Leu-enkephalin analogue, 100 µg/kg on postnatal days 2–6; day-7 liver growth, proliferation, nucleolar and redox assays.

Reported findings and study figures · Indexed original abstract; full methods and outcome tables not recovered
MeasureResultComparison, timing and statistics
DalarginReported normalization of gravimetric, proliferation and hepatocyte nucleolar measures
Non-opioid analogue: incomplete effectGravimetric and nucleolar parameters not normalized; proliferating-cell pool increasedRelated analogue is not Dalargin
Redox outcomesBoth preparations reduced free-radical oxidation and improved antioxidant defenses; numerical effects unavailable

Postnatal animal treatment, not maternal administration or human neonatal efficacy. Abstract gives no group n, exact numerical effects, comprehensive safety series or proof of normal adult liver function. The related analogue’s exact preparation must be verified separately before assigning its results to a specific NALE formulation.

Source for the extracted data ↗ · Checked 2026-11-08

Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.

Methods, limitations & source review

Study limitations

  • Postnatal animal treatment, not maternal administration or human neonatal efficacy.
  • Abstract gives no group n, exact numerical effects, comprehensive safety series or proof of normal adult liver function.
  • The related analogue’s exact preparation must be verified separately before assigning its results to a specific NALE formulation.

Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.

Document format: Publication record and available text

Review depth: Indexed original abstract; full methods and outcome tables not recovered

Related-report group: pregnancy-dalargin-neonatal-liver-2016. Reports in this group are not assumed to be independent trials.

Source access and review scope

Indexed original abstract; full methods and outcome tables not recovered

Recorded source-check date: 2026-11-08. This date does not imply a completed systematic review.

Source type: Original journal publication

Open original source or index record ↗

DOI: 10.1007/s10517-016-3576-y

Citation and original source

Original source: Pinaeva OG, Sazonova EN, Lebed'ko OA, Timoshin SS. Correction of Negative Effect of Antenatal Hypoxia on Liver Tissue Homeostasis in Newborn Albino Rats with Opioid Peptides Bulletin of experimental biology and medicine. 2016;162(2):203. PMID 27909965 2016.

Molekul research summary: https://molekul.io/research/pregnancy-dalargin-neonatal-liver-2016. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.

Bibliography entry

Related compound profiles

Editorial policy and evidence standards